Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease

Michael P. Mcdermott, Joseph Jankovic, Julie Carter, Stanley Fahn, Serge Gauthier, Christopher G. Goetz, Lawrence I. Golbe, William Koller, Anthony E. Lang, C. Warren Olanow, Ira Shoulson, Matthew B. Stern, Caroline M. Tanner, William J. Weiner

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

To identify characteristics of patients with early, untreated Parkinson's disease that are the most important predictors of rapid functional decline. Prospective observational study of a cohort of 800 patients with early, untreated Parkinson's disease who were involved in a multicenter, randomized, double-blind, controlled clinical trial of selegiline hydrochloride (l-deprenyl) and vitamin E (α-tocopherol). Time from randomization to the onset of disability that necessitated levodopa therapy (end point), as judged by the enrolling investigator. Stepwise Cox regression was used in combination with clinical judgment to identify the most important independent baseline predictors of the primary end point among a host of variables, including treatment with selegiline and vitamin E, global and specific clinical measures of disease severity, demographic variables, and neuropsychological test results. In addition to selegiline treatment and global disease severity measures, such as the stage according to the criteria of Hoehn and Yahr, impaired domestic capacity, and the activities of daily living score, the complex of postural instability/gait difficulty and bradykinesia were found to be the factors that were most highly associated with the risk of reaching the end point. The findings suggest that patients with Parkinson's disease whose early clinical presentation includes either postural instability/gait difficulty or bradykinesia are at high risk for rapid functional decline.

Original languageEnglish (US)
Pages (from-to)565-570
Number of pages6
JournalArchives of Neurology
Volume52
Issue number6
DOIs
StatePublished - 1995

Fingerprint

Selegiline
Levodopa
Parkinson Disease
Hypokinesia
Vitamin E
Gait
Tocopherols
Neuropsychological Tests
Controlled Clinical Trials
Therapeutics
Activities of Daily Living
Random Allocation
Observational Studies
Research Personnel
Demography
Prospective Studies
Therapy
Parkinson's Disease
Vitamins
Predictors

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Mcdermott, M. P., Jankovic, J., Carter, J., Fahn, S., Gauthier, S., Goetz, C. G., ... Weiner, W. J. (1995). Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease. Archives of Neurology, 52(6), 565-570. https://doi.org/10.1001/archneur.1995.00540300037010

Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease. / Mcdermott, Michael P.; Jankovic, Joseph; Carter, Julie; Fahn, Stanley; Gauthier, Serge; Goetz, Christopher G.; Golbe, Lawrence I.; Koller, William; Lang, Anthony E.; Olanow, C. Warren; Shoulson, Ira; Stern, Matthew B.; Tanner, Caroline M.; Weiner, William J.

In: Archives of Neurology, Vol. 52, No. 6, 1995, p. 565-570.

Research output: Contribution to journalArticle

Mcdermott, MP, Jankovic, J, Carter, J, Fahn, S, Gauthier, S, Goetz, CG, Golbe, LI, Koller, W, Lang, AE, Olanow, CW, Shoulson, I, Stern, MB, Tanner, CM & Weiner, WJ 1995, 'Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease', Archives of Neurology, vol. 52, no. 6, pp. 565-570. https://doi.org/10.1001/archneur.1995.00540300037010
Mcdermott, Michael P. ; Jankovic, Joseph ; Carter, Julie ; Fahn, Stanley ; Gauthier, Serge ; Goetz, Christopher G. ; Golbe, Lawrence I. ; Koller, William ; Lang, Anthony E. ; Olanow, C. Warren ; Shoulson, Ira ; Stern, Matthew B. ; Tanner, Caroline M. ; Weiner, William J. / Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease. In: Archives of Neurology. 1995 ; Vol. 52, No. 6. pp. 565-570.
@article{ce300aa6d602459ab586f2d1444722b4,
title = "Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease",
abstract = "To identify characteristics of patients with early, untreated Parkinson's disease that are the most important predictors of rapid functional decline. Prospective observational study of a cohort of 800 patients with early, untreated Parkinson's disease who were involved in a multicenter, randomized, double-blind, controlled clinical trial of selegiline hydrochloride (l-deprenyl) and vitamin E (α-tocopherol). Time from randomization to the onset of disability that necessitated levodopa therapy (end point), as judged by the enrolling investigator. Stepwise Cox regression was used in combination with clinical judgment to identify the most important independent baseline predictors of the primary end point among a host of variables, including treatment with selegiline and vitamin E, global and specific clinical measures of disease severity, demographic variables, and neuropsychological test results. In addition to selegiline treatment and global disease severity measures, such as the stage according to the criteria of Hoehn and Yahr, impaired domestic capacity, and the activities of daily living score, the complex of postural instability/gait difficulty and bradykinesia were found to be the factors that were most highly associated with the risk of reaching the end point. The findings suggest that patients with Parkinson's disease whose early clinical presentation includes either postural instability/gait difficulty or bradykinesia are at high risk for rapid functional decline.",
author = "Mcdermott, {Michael P.} and Joseph Jankovic and Julie Carter and Stanley Fahn and Serge Gauthier and Goetz, {Christopher G.} and Golbe, {Lawrence I.} and William Koller and Lang, {Anthony E.} and Olanow, {C. Warren} and Ira Shoulson and Stern, {Matthew B.} and Tanner, {Caroline M.} and Weiner, {William J.}",
year = "1995",
doi = "10.1001/archneur.1995.00540300037010",
language = "English (US)",
volume = "52",
pages = "565--570",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "6",

}

TY - JOUR

T1 - Factors Predictive of the Need for Levodopa Therapy in Early, Untreated Parkinson's Disease

AU - Mcdermott, Michael P.

AU - Jankovic, Joseph

AU - Carter, Julie

AU - Fahn, Stanley

AU - Gauthier, Serge

AU - Goetz, Christopher G.

AU - Golbe, Lawrence I.

AU - Koller, William

AU - Lang, Anthony E.

AU - Olanow, C. Warren

AU - Shoulson, Ira

AU - Stern, Matthew B.

AU - Tanner, Caroline M.

AU - Weiner, William J.

PY - 1995

Y1 - 1995

N2 - To identify characteristics of patients with early, untreated Parkinson's disease that are the most important predictors of rapid functional decline. Prospective observational study of a cohort of 800 patients with early, untreated Parkinson's disease who were involved in a multicenter, randomized, double-blind, controlled clinical trial of selegiline hydrochloride (l-deprenyl) and vitamin E (α-tocopherol). Time from randomization to the onset of disability that necessitated levodopa therapy (end point), as judged by the enrolling investigator. Stepwise Cox regression was used in combination with clinical judgment to identify the most important independent baseline predictors of the primary end point among a host of variables, including treatment with selegiline and vitamin E, global and specific clinical measures of disease severity, demographic variables, and neuropsychological test results. In addition to selegiline treatment and global disease severity measures, such as the stage according to the criteria of Hoehn and Yahr, impaired domestic capacity, and the activities of daily living score, the complex of postural instability/gait difficulty and bradykinesia were found to be the factors that were most highly associated with the risk of reaching the end point. The findings suggest that patients with Parkinson's disease whose early clinical presentation includes either postural instability/gait difficulty or bradykinesia are at high risk for rapid functional decline.

AB - To identify characteristics of patients with early, untreated Parkinson's disease that are the most important predictors of rapid functional decline. Prospective observational study of a cohort of 800 patients with early, untreated Parkinson's disease who were involved in a multicenter, randomized, double-blind, controlled clinical trial of selegiline hydrochloride (l-deprenyl) and vitamin E (α-tocopherol). Time from randomization to the onset of disability that necessitated levodopa therapy (end point), as judged by the enrolling investigator. Stepwise Cox regression was used in combination with clinical judgment to identify the most important independent baseline predictors of the primary end point among a host of variables, including treatment with selegiline and vitamin E, global and specific clinical measures of disease severity, demographic variables, and neuropsychological test results. In addition to selegiline treatment and global disease severity measures, such as the stage according to the criteria of Hoehn and Yahr, impaired domestic capacity, and the activities of daily living score, the complex of postural instability/gait difficulty and bradykinesia were found to be the factors that were most highly associated with the risk of reaching the end point. The findings suggest that patients with Parkinson's disease whose early clinical presentation includes either postural instability/gait difficulty or bradykinesia are at high risk for rapid functional decline.

UR - http://www.scopus.com/inward/record.url?scp=0029035622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029035622&partnerID=8YFLogxK

U2 - 10.1001/archneur.1995.00540300037010

DO - 10.1001/archneur.1995.00540300037010

M3 - Article

VL - 52

SP - 565

EP - 570

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 6

ER -